Our Team
Dr. Robert Grundy, CEO
Dr. Rob Grundy BSc PhD FRSB is a business leader with a focus on technology, enterprise and commercialisation with an established global professional network. Rob has spent over 23 years working as a Principal Scientist, CSO, BD Director and CEO for organisations such as Schering Plough, GSK, Cerebricon, Almac Group and CIGA Healthcare. He holds advisory positions in industry, government, and academia and has a passion for converting the potential of valuable scientific invention into commercially viable innovation.
Prof. Graham Ball, CSO
Graham is a world leading experts in artificial intelligence in healthcare. He leads the development and use of the Intellomx ANN technology. He has over 25 years’ experience of mathematical modelling and bioinformatics experience in the application of bioinformatics techniques to big biological data. He is an experienced commercial project manager and has acted as the bioinformatics consultant on numerous projects in the AI and ML space as lead consultant.
Simon Haworth, Director
Simon is a serial entrepreneur whose experience includes technology innovation and investment in Cambridge UK, Boston USA and Wuhan China. Former founder of listed investment company IPSO Ventures PLC. Simon’s commercial skills complement Prof Ball’s technical expertise.
Dr. Bill Mason, Director
Bill gained his PhD in medicine from Trinity College, Cambridge. He has founded several successful high technology life science companies which have been sold to global corporate ventures in drug discovery, diagnostics and regenerative medicine. He has conducted over 80 transactions in healthcare and life sciences in the last ten years, working with a portfolio of quoted and unquoted life science companies.
Investors
Intellomx is supported by a range of private and public investors.
